Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial

  1. Steg, P.G.
  2. Bhatt, D.L.
  3. James, S.K.
  4. Darlington, O.
  5. Hoskin, L.
  6. Simon, T.
  7. Fox, K.M.
  8. Leiter, L.A.
  9. Mehta, S.R.
  10. Harrington, R.A.
  11. Himmelmann, A.
  12. Ridderstråle, W.
  13. Andersson, M.
  14. Bueno, H.
  15. De Luca, L.
  16. Tank, A.
  17. Mellström, C.
  18. McEwan, P.
Aldizkaria:
European heart journal. Cardiovascular pharmacotherapy

ISSN: 2055-6845

Argitalpen urtea: 2022

Alea: 8

Zenbakia: 8

Orrialdeak: 777-785

Mota: Artikulua

DOI: 10.1093/EHJCVP/PVAC032 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus